Notes to the Consolidated Financial Statements as at and for the year ended March 31, 2024
Notes to the Consolidated Financial Statements as at and for the year ended March 31, 2024
8 Trade Receivables
Ageing of Projects in progress (at gross value)
(in Rupees million)
(in Rupees million)
Amount in IAUD for a period of
As at March 31, 2024
As at March 31, 2023
Particulars
Less than 1 year
1-2 years
2-3 years More than 3 years
Total
Trade receivables -
As at March 31, 2024 As at March 31, 2023
59 20
13 15
15 13
59 46
146
Unsecured, considered good Unsecured, credit impaired
3,825
3,454
94
- -
12
12
Breakup of nature of expenses which has been capitalised
Unbilled receivables - Unsecured, considered good
1,596 5,433
1,609 5,075
Sub Total
(in Rupees million)
Allowances for expected credit loss
(100)
(66)
As at March 31, 2024
As at March 31, 2023
Particulars
Current trade receivables
5,333
5,009
Salaries, wages and bonus
88 83
95
Ageing for Trade receivables : March 31, 2024
Other expenses
7
Total
171
102
Outstanding for following periods from due date of payment
7 Investments (Non-current)
Current but not due
More than 3 years
(in Rupees million)
Less than 6 Months
6 months – 1 year 1-2 years 2-3 years
Particulars
Total
As at March 31, 2024
As at March 31, 2023
Particulars
Trade receivables (i) U ndisputed Trade receivables – considered good (ii) U ndisputed Trade receivables – credit impaired
Investments (Non-current) A. Investment in equity instruments of Associates accounted under the equity method Investments in unquoted equity instruments Qure.ai Technologies Private Limited 2 50,000,000 (March 31, 2023: 250,000,000) equity shares of C 1 fully paid up (Refer note 37)
3,230
550
10
28
6
1
3,825
-
-
-
-
-
12
12
4,259
4,479
3,230
550
10
28
6
13
3,837 (100) 3,737 1,596 5,333
Less: Allowance for expected credit loss
Total carrying value
4,259
4,479
B. Common stock (Unquoted, measured at fair value through profit and loss) Commure, Inc.
Trade receivables - Unbilled
Total
33
-
(March 31, 2024 : 5,003 shares of common stock) (March 31, 2023 : Nil shares of common stock)
Ageing for Trade receivables : March 31, 2023
C. Preferred stock (Unquoted, measured at fair value through profit and loss) Commure, Inc. (March 31, 2024 : 6,941 shares of series D preferred stock) (March 31, 2023 : Nil shares of series D preferred stock) D. Preferred stock (Unquoted, measured at fair value through profit and loss) RX.health, Inc.
Outstanding for following periods from due date of payment
46
-
Current but not due
More than 3 years
Less than 6 Months
6 months – 1 year 1-2 years 2-3 years
Particulars
Total
Trade receivables (i) U ndisputed Trade receivables – considered good (ii) U ndisputed Trade receivables – credit impaired
-
12
3,103
285
45
17
4
-
3,454
(March 31, 2024 : Nil shares of series Seed-2 preferred stock) (March 31, 2023 : 658,761 shares of series Seed-2 preferred stock)
-
-
-
-
-
12
12
D. Equity
(Unquoted, measured at amortised cost) Qi-Cap Investments Private Limited* (March 31, 2024 : 132,567 shares of face value C 1 each March 31, 2023 : Nil)
3,103
285
45
17
4
12
3,466 (66) 3,400 1,609 5,009
0
-
Less: Allowance for expected credit loss
79
12
Trade receivables - Unbilled
Total (non-current)
4,338
4,491
Total
Investments (Current)
(Measured at fair value through profit and loss) Investment in liquid mutual funds units (unquoted)
4,455 4,455 8,793
2,906 2,906
Total other investments
(a) Aggregate carrying value of unquoted investments 7,397 Note 1 : During the year ended March 31, 2024, the Group has received common stock and series D preferred stock of Commure, Inc in exchange of RX.Health, Inc. series Seed-2 preferred stock on account of merger of RX.health, Inc. to Commure, Inc. Accordingly, the investment is fair valued and gain of C 67 million is recognised in the Consolidated Statement of Profit and Loss. *Amount less than C 1 million
216
217
Fractal Analytics Limited | Annual Report 2023-24
Made with FlippingBook - PDF hosting